Peter C Adamson Selected Research

ABT751

6/2014	Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: a report from the Children's Oncology Group (ANBL0621).
9/2010	Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.
2/2008	A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors.
8/2006	A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C Adamson Research Topics

Disease

74	Neoplasms (Cancer) 01/2022 - 11/2003
15	Neuroblastoma 01/2021 - 02/2004
11	Leukemia 01/2020 - 03/2007
11	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018 - 09/2007
10	Neutropenia 05/2013 - 11/2005
9	Thrombocytopenia (Thrombopenia) 05/2014 - 12/2004
8	Ewing Sarcoma (Sarcoma, Ewing) 01/2014 - 11/2006
7	Fatigue 02/2013 - 11/2006
5	Osteosarcoma (Osteogenic Sarcoma) 08/2014 - 05/2004
4	Lymphoma (Lymphomas) 11/2021 - 09/2007
4	Sarcoma (Soft Tissue Sarcoma) 01/2016 - 11/2006
4	Nausea 02/2013 - 01/2008
4	Diarrhea 11/2012 - 04/2009
4	Hypertension (High Blood Pressure) 11/2012 - 07/2006
4	Rhabdomyosarcoma 03/2012 - 01/2008
4	Medulloblastoma 03/2008 - 12/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2015 - 11/2007
3	Anorexia 05/2014 - 04/2010
3	Vomiting 02/2013 - 01/2008
3	Seizures (Absence Seizure) 01/2013 - 10/2004
3	Glioma (Gliomas) 08/2011 - 08/2008
3	Hypokalemia 03/2011 - 04/2009
3	Headache (Headaches) 12/2010 - 01/2008
3	Body Weight (Weight, Body) 05/2010 - 11/2005
3	Abdominal Pain (Pain, Abdominal) 04/2010 - 01/2008
3	Wilms Tumor (Wilm's Tumor) 01/2010 - 10/2007
3	Hypotension (Low Blood Pressure) 03/2007 - 12/2004
3	Critical Illness (Critically Ill) 11/2005 - 11/2003
2	Disease Progression 01/2021 - 09/2005
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2020 - 05/2013
2	Febrile Neutropenia 01/2020 - 03/2007
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 02/2009
2	Hematologic Neoplasms (Hematological Malignancy) 07/2015 - 02/2011
2	Residual Neoplasm 07/2015 - 12/2011
2	Philadelphia Chromosome 05/2015 - 03/2011
2	Hyperglycemia 02/2013 - 01/2008
2	Anemia 02/2013 - 10/2007
2	Exanthema (Rash) 02/2013 - 11/2012
2	Absence Epilepsy (Childhood Absence Epilepsy) 01/2013 - 03/2010
2	Synovial Sarcoma (Synovioma) 01/2010 - 02/2008
2	Candidiasis (Moniliasis) 08/2009 - 11/2005
2	Primitive Neuroectodermal Tumors (PNET) 11/2006 - 12/2004

Drug/Important Bio-Agent (IBA)

18	Pharmaceutical PreparationsIBA 01/2022 - 11/2003
7	Biological ProductsIBA 02/2009 - 02/2004
6	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 12/2004
6	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 01/2007
6	Methotrexate (Mexate)FDA LinkGeneric 12/2011 - 05/2004
5	Temozolomide (Temodar)FDA LinkGeneric 05/2014 - 11/2007
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 04/2007
4	ABT751IBA 06/2014 - 08/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 05/2014 - 10/2007
4	FenretinideIBA 01/2014 - 01/2006
4	RetinoidsIBA 01/2014 - 01/2006
4	Pemetrexed (MTA)FDA Link 02/2013 - 04/2007
3	Rituximab (Mabthera)FDA Link 11/2021 - 09/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 04/2007
3	CrizotinibIBA 01/2021 - 05/2013
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 12/2010
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 09/2005
3	Alanine Transaminase (SGPT)IBA 05/2014 - 11/2012
3	Topotecan (Hycamtin)FDA LinkGeneric 01/2014 - 11/2006
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2013 - 03/2010
3	Transaminases (Aminotransferases)IBA 08/2011 - 01/2008
3	esmolol (Brevibloc)FDA LinkGeneric 08/2008 - 11/2003
3	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2008 - 04/2006
2	Histone Deacetylase InhibitorsIBA 01/2022 - 08/2006
2	Vorinostat FDA Link 01/2022 - 08/2010
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 05/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 08/2011
2	Asparaginase (Elspar)FDA Link 01/2018 - 12/2014
2	epratuzumabIBA 07/2015 - 08/2008
2	cixutumumabIBA 03/2014 - 01/2012
2	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 12/2004
2	Cytotoxins (Cytolysins)IBA 01/2014 - 04/2006
2	Isotretinoin (Accutane)FDA LinkGeneric 01/2014 - 12/2011
2	EnzymesIBA 05/2013 - 04/2009
2	Ethosuximide (Zarontin)FDA LinkGeneric 01/2013 - 03/2010
2	Lamotrigine (Lamictal)FDA LinkGeneric 01/2013 - 03/2010
2	MLN 8237IBA 11/2012 - 09/2010
2	Alkaline PhosphataseIBA 11/2012 - 08/2011
2	Sunitinib (Sutent)FDA Link 04/2012 - 08/2011
2	Phosphotransferases (Kinase)IBA 12/2011 - 01/2007
2	lissamine rhodamine B (sulforhodamine B)IBA 12/2011 - 05/2010
2	CreatinineIBA 03/2011 - 03/2007
2	dimemorfan (AT 17)IBA 12/2010 - 08/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2010 - 04/2009
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2010 - 10/2007
2	Lipase (Acid Lipase)FDA Link 04/2009 - 03/2008
2	Amylases FDA Link 04/2009 - 03/2008
2	Caspofungin (Cancidas)FDA Link 04/2009 - 11/2005
2	ErbB Receptors (EGF Receptor)IBA 10/2008 - 09/2005
2	Lomustine (CCNU)FDA Link 08/2008 - 12/2004
2	Monoclonal AntibodiesIBA 08/2008 - 03/2006
2	Tubulin ModulatorsIBA 02/2008 - 08/2006
2	Bortezomib (Velcade)FDA Link 03/2007 - 12/2004
2	Proteasome InhibitorsIBA 03/2007 - 12/2004

Therapy/Procedure

20	Therapeutics 01/2022 - 11/2003
15	Drug Therapy (Chemotherapy) 12/2020 - 11/2003
5	Radiotherapy 01/2022 - 12/2004
3	Intravenous Infusions 02/2013 - 11/2006